Terumo BCT Executive and Leadership Team

Antoinette Gawin, the President & Chief Executive Officer at Terumo BCT, directs the company's overarching strategy and global operations. Overseeing all business units, Gawin ensures alignment with Terumo BCT's mission to advance blood component and cellular technologies. This leadership role involves driving innovation in apheresis collections, therapeutic apheresis, cell therapy systems, whole blood processing, and pathogen reduction technologies. By focusing on market expansion and product development, Antoinette Gawin directly impacts the company's ability to serve healthcare providers worldwide. The President & Chief Executive Officer's vision guides the organization's commitment to improving patient outcomes and advancing medical science through cutting-edge solutions.

Russell Spinney, the Chief Financial Officer at Terumo BCT, manages the company's financial health and strategic fiscal planning. Overseeing all financial operations, Spinney ensures robust resource allocation to support Terumo BCT's development of blood components and cellular technologies. This critical role involves managing investments in apheresis collections, therapeutic apheresis, cell therapy systems, whole blood processing, and pathogen reduction technologies. By optimizing financial performance and driving fiscal discipline, Russell Spinney directly contributes to the company's sustained growth and market leadership. The Chief Financial Officer's expertise underpins the organization's capacity to fund research, expand global reach, and maintain operational excellence in the competitive medical technology sector.

Stuart Bedell, the Division Chief Financial Officer, Plasma Innovations Business Unit at Terumo BCT, spearheads financial strategy specifically for the plasma innovations segment. Overseeing the fiscal operations of this specialized unit, Bedell ensures financial resources effectively support advancements in plasma processing and related technologies. This role is integral to driving the financial success and strategic direction of Terumo BCT's plasma-focused product lines. By managing budgets, forecasting revenue, and analyzing financial performance, Stuart Bedell directly enables the unit's contribution to the company's overall mission. The Division Chief Financial Officer's focused financial acumen is essential for optimizing investments and maximizing the impact of plasma innovations within the broader organization.

Bon Lopez, the Senior Vice President, Global Human Resources (Chief People Officer) at Terumo BCT, leads the company's comprehensive human capital strategy. Overseeing talent acquisition, development, and employee engagement across global operations, Lopez ensures Terumo BCT cultivates a high-performing workforce dedicated to advancing blood component and cellular technologies. This pivotal role involves fostering a culture that supports innovation in apheresis collections, therapeutic apheresis, cell therapy systems, whole blood processing, and pathogen reduction technologies. By championing employee well-being and professional growth, Bon Lopez directly strengthens the organization's capacity to achieve its mission. The Senior Vice President, Global Human Resources (Chief People Officer)'s leadership is fundamental to attracting and retaining the talent necessary for sustained success and market leadership.